Erratum: A medicinal chemist' guide to molecular interactions (Journal of Medicinal Chemistry (2010) 53 (5061) DOI: 10.1021/jm100112j);A medicinal chemist's guide to molecular interactions

Journal of Medicinal Chemistry

Volumn 53, Issue 14, 2010, Pages 5061-5084

  Bissantz, Caterina ^a   Kuhn, Bernd ^a   Stahl, Martin ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ANALYSIS; CHEMICAL BINDING; CHEMICAL STRUCTURE; ENTHALPY; ENTROPY; MOLECULAR INTERACTION; REVIEW;

EID: 77953631827     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm100950p     Document Type: Erratum

References (228)

1. Allen, F. H. The Cambridge Structural Database: a quarter of a million crystal structures and rising Acta Crystallogr. 2002, B58, 380-388
2. Bernstein, F. C.; Koetzle, T. E.; Williams, G. J. B.; Meyer, J., E. F.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. The protein data bank: a computer-based archival file for macromolecular structures J. Mol. Biol. 1977, 112, 535-542; http://www.rcsb.org/pdb/
3. Mark, A. E.; van Gunsteren, W. F. Decomposition of the free energy of a system in terms of specific interactions. Implications for theoretical and experimental studies J. Mol. Biol. 1994, 240, 167-176
4. Dill, K. A. Additivity principles in biochemistry J. Biol. Chem. 1997, 272, 701-704
5. Olsson, T. S. G.; Williams, M. A.; Pitt, W. R.; Ladbury, J. E. The thermodynamics of protein-ligand interaction and solvation: insights for ligand design J. Mol. Biol. 2008, 384, 1002-1017
6. http://scorpio.biophysics.ismb.lon.ac.uk/scorpio.html (accessed March 12, 2010).
7. Chervenak, M. C.; Toone, E. J. A direct measure of the contribution of solvent reorganization to the enthalpy of binding J. Am. Chem. Soc. 1994, 116, 10533-10539
8. Gilson, M. K.; Zhou, H.-X. Calculation of protein-ligand binding affinities Annu. Rev. Biophys. Biomol. Struct. 2007, 36, 21-42
9. Myszka, D. G.; Abdiche, Y. N.; Arisaka, F.; Byron, O.; Eisenstein, E.; Hensley, P.; Thomson, J. A.; Lombardo, C. R.; Schwarz, F.; Stafford, W.; Doyle, M. L. The ABRF-MIRG'02 study: assembly state, thermodynamic, and kinetic analysis of an enzyme/inhibitor interaction J. Biomol. Tech. 2003, 14, 247-269
10. Tellinghuisen, J. Calibration in isothermal titration calorimetry: heat and cell volume from heat of dilution of NaCl(aq) Anal. Biochem. 2007, 360, 47-55
11. Klebe, G.; Dullweber, F.; Boehm, H.-J. Thermodynamic Models of Drug-Receptor Interactions: A General Introduction. In Drug-Receptor Thermodynamics: Introduction and Applications; Raffa, R. B., Ed.; Wiley: Chichester, U.K., 2001; pp 83 - 103.
12. Dullweber, F.; Stubbs, M. T.; Musil, D.; Stürzebecher, J.; Klebe, G. Factorising ligand affinity: a combined thermodynamic and crystallographic study of trypsin and thrombin inhibition J. Mol. Biol. 2001, 313, 593-614
13. Freire, E. A Thermodynamic Guide to Affinity Optimization of Drug Candidates. In Protein Reviews; Waksman, G., Ed.; Springer: New York, 2005; Vol. 3, pp 291 - 307.
14. Freire, E. Do enthalpy and entropy distinguish first in class from best in class? Drug Discovery Today 2008, 13, 869-874
15. Exner, O. Entropy-enthalpy compensation and anticompensation: solvation and ligand binding Chem. Commun. 2000, 1655-1656
16. Sharp, K. Entropy-enthalpy compensation: fact or artifact? Protein Sci. 2001, 10, 661-667
17. Gallicchio, E.; Kubo, M. M.; Levy, R. M. Entropy-enthalpy compensation in solvation and ligand binding revisited J. Am. Chem. Soc. 1998, 120, 4526-4527
18. Ford, D. M. Enthalpy-entropy compensation is not a general feature of weak association J. Am. Chem. Soc. 2005, 127, 16167-16170
19. Dunitz, J. D. Win some, lose some: enthalpy-entropy compensation in weak molecular interactions Chem. Biol. 1995, 2, 709-712
20. Houk, K. N.; Leach, A. G.; Kim, S. P.; Zhang, X. Binding affinities of host-guest, protein-ligand and protein-transition state complexes Angew. Chem., Int. Ed. 2003, 42, 4872-4897
21. Whitesides, G. M.; Krishnamurthy, V. M. Designing ligands to bind proteins Q. Rev. Biophys. 2005, 38, 385-395
22. Williams, D. H.; Stephens, E.; O'Brien, D. P.; Zhou, M. Understanding noncovalent interactions: ligand binding energy and catalytic efficiency from ligand-induced reductions in motion within receptors and enzymes Angew. Chem., Int. Ed. 2004, 43, 6596-6616
23. Frederick, K. K.; Marlow, M. S.; Valentine, K. G.; Wand, J. Conformational entropy in molecular recognition by proteins Nature 2007, 448, 325-330
24. Williams, D. H.; Stephens, E.; Zhou, M. Ligand binding energy and catalytic efficiency from improved packing within receptors and enzymes J. Mol. Biol. 2003, 329, 389-399
25. Hunter, C. A.; Tomas, S. Cooperativity, partially bound states, and enthalpy-entropy compensation Chem. Biol. 2003, 10, 1023-1032
26. Williams, D. H.; Davies, N. L.; Koivisto, J. J. Importance of structural tightening, as opposed to partially bound states, in the determination of chemical shift changes at noncovalently bonded interfaces J. Am. Chem. Soc. 2004, 126, 14267-14272
27. Chekmeneva, E.; Hunter, C. A.; Packer, M. J.; Turega, S. M. Evidence for partially bound states in cooperative molecular recognition interfaces J. Am. Chem. Soc. 2008, 130, 17718-17725
28. Talhout, R.; Villa, A.; Mark, A. E.; Engberts, J. B. F. N. Understanding binding affinity: a combined isothermal titration calorimetry/molecular dynamics study of the binding of a series of hydrophobically modified benzamidinium chloride inhibitors to trypsin J. Am. Chem. Soc. 2003, 125, 10570-10579
29. Krishnamurthy, V. M.; Bohall, B. R.; Semetey, V.; Whitesides, G. M. The paradoxical thermodynamic basis for the interaction of ethylene glycol, glycine, and sarcosine chains with bovine carbonic anhydrase II: an unexpected manifestation of enthalpy/entropy compensation J. Am. Chem. Soc. 2006, 128, 5802-5812
30. Muley, L.; Baum, B.; Smolinski, M.; Freindorf, M.; Heine, A.; Klebe, G.; Hangauer, D. Enhancement of hydrophobic interactions and hydrogen bond strength by cooperativity: synthesis, modeling and MD-simulations of a congeneric series of thrombin inhibitors J. Med. Chem. 2010, 53, 2126-2135
31. Baum, B.; Muley, L.; Smolinski, M.; Heine, A.; Hangauer, D.; Klebe, G. Non-additivity of functional group contributions in protein-ligand binding: a comprehensive study by crystallography and isothermal titration calorimetry. J. Mol. Biol. 2010, DOI: 10.1016/j.jmb.2010.02.007.
32. Scatena, L. F.; Brown, M. G.; Richmond, G. L. Water at hydrophobic surfaces: weak hydrogen bonding and strong orientation effects Science 2001, 292, 908-912
33. Finney, J. L.; Soper, A. K. Solvent structure and perturbations in solutions of chemical and biological importance Chem. Soc. Rev. 1994, 23, 1-10
34. Dill, K. A.; Truskett, T. M.; Vlachy, V.; Hribar-Lee, B. Modeling water, the hydrophobic effect, and ion solvation Annu. Rev. Biophys. Biomol. Struct. 2005, 34, 173-199
35. Meyer, E. A.; Castellano, R. K.; Diederich, F. Interactions with aromatic rings in chemical and biological recognition Angew. Chem., Int. Ed. 2003, 42, 1210-1250
36. Homans, S. W. Water, water everywhere - except where it matters? Drug Discovery Today 2007, 12, 534-539
37. Syme, N. R.; Dennis, C.; Phillips, S. E. V.; Homans, S. W. Origin of heat capacity changes in a "nonclassical" hydrophobic interaction ChemBioChem 2007, 8, 1509-1511
38. Berne, B. J.; Weeks, J. D.; Zhou, R. Dewetting and hydrophobic interaction in physical and biological systems Annu. Rev. Phys. Chem. 2009, 60, 85-103
39. 1H NMR shift calculation J. Am. Chem. Soc. 2006, 128, 4831-4841
40. Young, R. J.; Campbell, M.; Borthwick, A. D.; Brown, D.; Burns-Kurtis, C. L.; Chan, C.; Convery, M. A.; Crowe, M. C.; Dayal, S.; Diallo, H.; Kelly, H. A.; King, N. P.; Kleanthous, S.; Mason, A. M.; Mordaunt, J. E.; Patel, C.; Pateman, A. J.; Senger, S.; Shah, G. P.; Smith, P. W.; Watson, N. S.; Weston, H. E.; Zhou, P. Structure- and property-based design of factor Xa inhibitors: pyrrolidin-2-ones with acyclic alanyl amides as P4 motifs Bioorg. Med. Chem. Lett. 2006, 16, 5953-5957
41. Abel, R.; Young, T.; Farid, R.; Berne, B. J.; Friesner, R. A. Role of the active-site solvent in the thermodynamics of factor Xa ligand binding J. Am. Chem. Soc. 2008, 130, 2817-2831
42. Young, T.; Abel, R.; Kim, B.; Berne, B. J.; Friesner, R. A. Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 808-813
43. Levitt, M.; Park, B. H. Water: now you see it, now you don't Structure 1993, 1, 223-226
44. Ringe, D.; Mattos, C. Analysis of the binding surfaces of proteins Med. Res. Rev. 1999, 19, 321-331
45. Ladbury, J. E. Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design Chem. Biol. 1996, 3, 973-980
46. Poornima, C. S.; Dean, P. M. Hydration in drug design. 2. Influence of local site surface shape on water binding J. Comput.-Aided Mol. Des. 1995, 9, 513-520
47. http://www.ccdc.cam.ac.uk/products/life-sciences/relibase/ (accessed March 12, 2010).
48. Dunitz, J. D. The entropic cost of bound water in crystals and biomolecules Science 1994, 264, 670
49. Denisov, V. P.; Venu, K.; Peters, J.; Hoerlein, H. D.; Halle, B. Orientational disorder and entropy of water in protein cavities J. Phys. Chem. B 1997, 101, 9380-9389
50. Matthews, B. W.; Liu, L. A review about nothing: are apolar cavities in proteins really empty? Protein Sci. 2009, 18, 494-502
51. Mao, Y.; Ratner, M. A.; Jarrold, M. F. One water molecule stiffens a protein J. Am. Chem. Soc. 2000, 122, 2950-2951
52. Fischer, S.; Verma, C. S. Binding of buried structural water increases the flexibility of proteins Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 9613-9615
53. Barillari, C.; Taylor, J.; Viner, R.; Essex, J. W. Classification of water molecules in protein binding sites J. Am. Chem. Soc. 2007, 129, 2577-2587
54. Michel, J.; Tirado-Rives, J.; Jorgensen, W. L. Energetics of displacing water molecules from protein binding sites: consequences for ligand optimization J. Am. Chem. Soc. 2009, 131, 15403-15411
55. Garcia-Sosa, A. T.; Mancera, R. L.; Dean, P. M. WaterScore: a novel method for distinguishing between bound and displaceable water molecules in the crystal structure of the binding site of protein-ligand complexes J. Mol. Model. 2003, 9, 172-182
56. Amadasi, A.; Surface, J. A.; Spyrakis, F.; Cozzini, P.; Mozzarelli, A.; Kellogg, G. E. Robust classification of "relevant" water molecules in putative protein binding sites J. Med. Chem. 2008, 51, 1063-1067
57. Boehm, H.-J.; Boehringer, M.; Bur, D.; Gmuender, H.; Huber, W.; Klaus, W.; Kostrewa, D.; Kuehne, H.; Luebbers, T.; Meunier-Keller, N.; Mueller, F. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening J. Med. Chem. 2000, 43, 2664-2674
58. Garcia-Sosa, A. T.; Firth-Clark, S.; Mancera, R. L. Including tightly-bound water molecules in de novo drug design. Exemplification through the in silico generation of poly(ADP-ribose)polymerase ligands J. Chem. Inf. Model. 2005, 45, 624-633
59. Wissner, A.; Berger, D. M.; Boschelli, D. H.; Floyd, M. B., Jr.; Greenberger, L. M.; Gruber, B. C.; Johnson, B. D.; Mamuya, N.; Nilakantan, R.; Reich, M. F.; Shen, R.; Tsou, H.-R.; Upeslacis, E.; Wang, Y. F.; Fei, B. W.; Ye, F.; Zhang, N. 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors J. Med. Chem. 2000, 43, 3244
60. Liu, C.; Wrobleski, S. T.; Lin, J.; Ahmed, G.; Metzger, A.; Wityak, J.; Gillooly, K. M.; Shuster, D. J.; McIntyre, K. W.; Pitt, S.; Shen, D. R.; Zhang, R. F.; Zhang, H.; Doweyko, A. M.; Diller, D.; Henderson, I.; Barrish, J. C.; Dodd, J. H.; Schieven, G. L.; Leftheris, K. 5-Cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38.alpha. MAP kinase J. Med. Chem. 2005, 48, 6261-6270
61. Chen, J. M.; Xu, S. L.; Wawrzak, Z.; Basarab, G. S.; Jordan, D. B. Structure-based design of potent inhibitors of scytalone dehydratase: displacement of a water molecule from the active site Biochemistry 1998, 37, 17735-17744
62. Ω- nitro- l -arginine-containing peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Displacement of the heme structural water J. Med. Chem. 2007, 50, 2089-2099
63. Campiani, G.; Kozlkowskl, A. P.; Wang, S.; Ming, L.; Naccl, V.; Saxena, A.; Doctor, B. P. Synthesis and anticholinesterase activity of huperzine A analogues containing phenol and catechol replacements for the pyridone ring Bioorg. Med. Chem. Lett. 1998, 8, 1413-1418
64. Karplus, P. A.; Faerman, C. Ordered water in macromolecular structure Curr. Opin. Struct. Biol. 1994, 4, 770-776
65. Henchman, R. H.; McCammon, J. A. Extracting hydration sites around proteins from explicit water simulations J. Comput. Chem. 2002, 23, 861-869
66. Tame, J. R. H.; Sleigh, S. H.; Wilkinson, A. J.; Ladbury, J. E. The role of water in sequence-independent ligand binding by an oligopeptide transporter protein Nat. Struct. Biol. 1996, 3, 998-1001
67. Davies, T. G.; Hubbard, R. E.; Tame, J. R. H. Relating structure to thermodynamics: the crystal structures and binding affinity of eight OppA-peptide complexes Protein Sci. 1999, 8, 1432-1444
68. Ritschel, T.; Kohler, P. C.; Neudert, G.; Heine, A.; Diederich, F.; Klebe, G. How to replace the residual solvation shell of polar active site residues to achieve nanomolar inhibition of tRNA-guanine transglycosylase ChemMedChem 2009, 4, 2012-2023
69. Stengl, B.; Meyer, E. A.; Heine, A.; Brenk, R.; Diederich, F.; Klebe, G. Crystal structures of tRNA-guanine transglycosylase (TGT) in complex with novel and potent inhibitors unravel pronounced induced-fit adaptations and suggest dimer formation upon substrate binding J. Mol. Biol. 2007, 370, 492-511
70. Lee, J.; Kim, S.-H. Water polygons in high-resolution protein crystal structures Protein Sci. 2009, 18, 1370-1376
71. Vaitheeswaran, S.; Yin, H.; Rasaiah, J. C.; Hummer, G. Water clusters in nonpolar cavities Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 17002-17005
72. Xantheas, S. S. Cooperativity and hydrogen bonding network in water clusters Chem. Phys. 2000, 258, 225-231
73. Brameld, K. A.; Kuhn, B.; Reuter, D. C.; Stahl, M. Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis J. Chem. Inf. Model. 2008, 48, 1-24
74. Taylor, R.; Kennard, O.; Versichel, W. Geometry of the imino-carbonyl (N-HO:C) hydrogen bond. 1. Lone-pair directionality J. Am. Chem. Soc. 1983, 105, 5761-5766
75. Lommerse, J. P. M.; Price, S. L.; Taylor, R. Hydrogen bonding of carbonyl, ether, and ester oxygen atoms with alkanol hydroxyl groups J. Comput. Chem. 1997, 18, 757-774
76. Nobeli, I.; Price, S. L.; Lommerse, J. P. M.; Taylor, R. Hydrogen bonding properties of oxygen and nitrogen acceptors in aromatic heterocycles J. Comput. Chem. 1997, 18, 2060-2074
77. Bruno, I. J.; Cole, J. C.; Lommerse, J. P. M.; Rowland, R. S.; Taylor, R.; Verdonk, M. L. IsoStar: a library of information about nonbonded interactions J. Comput.-Aided Mol. Des. 1997, 11, 525-537
78. Boer, D. R.; Kroon, J.; Cole, J. C.; Smith, B.; Verdonk, M. L. SuperStar: comparison of CSD and PDB-based interaction fields as a basis for the prediction of protein-ligand interactions J. Mol. Biol. 2001, 313, 275-287
79. Grzybowski, B. A.; Ishchenko, A. V.; DeWitte, R. S.; Whitesides, G. M.; Shaknovich, E. I. Development of a knowledge-based potential for crystals of small organic molecules: calculation of energy surfaces for C - OH-N hydrogen bonds J. Phys. Chem. B 2000, 104, 7293-7298
80. Morozov, A. V.; Kortemme, T.; Tsemekhman, K.; Baker, D. Close agreement between the orientation dependence of hydrogen bonds observed in protein structures and quantum mechanical calculations Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 6946-6951
81. Davis, A. M.; Teague, S. J.; Kleywegt, G. J. Application and limitations of X-ray crystallographic data in structure-based ligand and drug design Angew. Chem., Int. Ed. 2003, 42, 2718-2736
82. DePristo, M. A.; Bakker, P. I. W.; Blundell, T. L. Heterogeneity and inaccuracy in protein structures solved by X-ray crystallography Structure 2004, 12, 831-838
83. Görbitz, C. H.; Etter, M. C. Hydrogen bonds to carboxylate groups. The question of three-center interactions J. Chem. Soc., Perkin Trans. 2 1992, 131-135
84. Davis, A. M.; Teague, S. J. Hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis Angew. Chem., Int. Ed. 1999, 38, 736-749
85. Kubinyi, H. Hydrogen Bonding, the Last Mystery in Drug Design? In Pharmacokinetic Optimization in Drug Research; Testa, B.; van de Waterbeemd, H.; Folkers, G.; Guy, R., Eds.; Wiley-VCH: Weinheim, Germany, 2001; pp 513 - 524.
86. Williams, M. A.; Ladbury, J. E. Hydrogen bonds in protein-ligand complexes Methods Princ. Med. Chem. 2003, 19, 137-161
87. Hunter, C. A. Quantifying intermolecular interactions: guidelines for the molecular recognition toolbox Angew. Chem., Int. Ed. 2004, 43, 5310-5324
88. McDonald, I. K.; Thornton, J. M. Satisfying hydrogen bonding potential in proteins J. Mol. Biol. 1994, 238, 777-793
89. Fleming, P. J.; Rose, G. D. Do all backbone polar groups in proteins form hydrogen bonds? Protein Sci. 2005, 14, 1911-1917
90. Efimov, A. V.; Brazhnikov, E. V. Relationship between intramolecular hydrogen bonding and solvent accessibility of side-chain donors and acceptors in proteins FEBS Lett. 2003, 554, 389-393
91. Barratt, E.; Bronowska, A.; Vondrasek, J.; Cerny, J.; Bingham, R.; Phillips, S.; Homans, S. W. Thermodynamic penalty arising from burial of a ligand polar group within a hydrophobic pocket of a protein receptor J. Mol. Biol. 2006, 362, 994-1003
92. Morgan, B. P.; Scholtz, J. M.; Ballinger, M. D.; Zipkin, I. D.; Bartlett, P. A. Differential binding energy: a detailed evaluation of the influence of hydrogen bonding and hydrophobic groups on the inhibition of thermolysin by phosphorus-containing inhibitors J. Am. Chem. Soc. 1991, 113, 297-301
93. McComas, C. C.; Crowley, B. M.; Boger, D. L. Partitioning the loss in vancomycin binding affinity for d -Ala- d -Lac into lost H-bond and repulsive lone pair contributions J. Am. Chem. Soc. 2003, 125, 9314-9315
94. Foloppe, N.; Fisher, L. M.; Howes, R.; Kierstan, P.; Potter, A.; Robertson, A. G. S.; Surgenor, A. E. Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity J. Med. Chem. 2005, 48, 4332-4345
95. Leftheris, K.; Ahmed, G.; Chan, R.; Dyckman, A. J.; Hussain, Z.; Ho, K.; Hynes, J., Jr.; Letourneau, J.; Li, W.; Lin, S.; Metzger, A.; Moriarty, K. J.; Riviello, C.; Shimshock, Y.; Wen, J.; Wityak, J.; Wrobleski, S. T.; Wu, H.; Wu, J.; Desai, M.; Gillooly, K. M.; Lin, T. H.; Loo, D.; McIntyre, K. W.; Pitt, S.; Shen, D. R.; Shuster, D. J.; Zhang, R.; Diller, D.; Doweyko, A.; Sack, J.; Baldwin, J.; Barrish, J.; Dodd, J.; Henderson, I.; Kanner, S.; Schieven, G. L.; Webb, M. The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase J. Med. Chem. 2004, 47, 6283-6291
96. Abraham, M. H.; Platts, J. A. Hydrogen bond structural group constants J. Org. Chem. 2001, 66, 3484-3491
97. Laurence, C.; Brameld, K. A.; Graton, J.; Le Questel, J.-Y.; Renault, E. The pKBHX database: toward a better understanding of hydrogen-bond basicity for medicinal chemists J. Med. Chem. 2009, 52, 4073-4086
98. Hagelin, H.; Murray, J. S.; Brinck, T.; Berthelot, M.; Politzer, P. Family-independent relationships between computed molecular surface quantities and solute hydrogen bond acidity/basicity and solute-induced methanol O-H infrared frequency shifts Can. J. Chem. 1995, 73, 483-488
99. Gancia, E.; Montana, J. G.; Manallack, D. T. Theoretical hydrogen bonding parameters for drug design J. Mol. Graph. Modell. 2001, 19, 349-362
100. Hao, M.-H. Theoretical calculation of hydrogen-bonding strength for drug molecules J. Chem. Theory Comput. 2007, 2, 863-872
101. Kenny, P. W. Hydrogen bonding, electrostatic potential, and molecular design J. Chem. Inf. Model. 2009, 49, 1234-1244
102. Nocker, M.; Handschuh, S.; Tautermann, C.; Liedl, K. R. Theoretical Prediction of Hydrogen Bond Strength for use in Molecular Modeling J. Chem. Inf. Model. 2009, 49, 2067-2076
103. Bingham, A. H.; Davenport, R. J.; Gowers, L.; Knight, R. L.; Lowe, C.; Owen, D. A.; Parry, D. M.; Pitt, W. R. A novel series of potent and selective IKK2 inhibitors Bioorg. Med. Chem. Lett. 2004, 14, 409-412
104. Morris, J. J.; Hughes, L. R.; Glen, A. T.; Taylor, P. J. Non-steroidal antiandrogens. Design of novel compounds based on an infrared study of the dominant conformation and hydrogen-bonding properties of a series of anilide antiandrogens J. Med. Chem. 1991, 34, 447-455
105. Koch, O.; Bocola, M.; Klebe, G. Cooperative effects in hydrogen-bonding of protein secondary structure elements: a systematic analysis of crystal data using Secbase Proteins 2005, 61, 310-317
106. DeChancie, J.; Houk, K. N. The origins of femtomolar protein-ligand binding: hydrogen-bond cooperativity and desolvation energetics in the biotin-(strept)avidin binding site J. Am. Chem. Soc. 2007, 129, 5419-5429
107. Tsemekhman, K.; Goldschmidt, L.; Eisenberg, D.; Baker, D. Cooperative hydrogen bonding in amyloid formations Protein Sci. 2007, 16, 761-764
108. Jadzyn, J.; Zywucki, B. Molecular structure of hydrogen bonded N, N ′-diethylurea in nonpolar solvents J. Mol. Struct. 1987, 158, 293-300
109. Panigrahi, S. K.; Desiraju, G. R. Strong and weak hydrogen bonds in the protein-ligand interface Proteins 2007, 67, 128-141
110. Etter, M. C. Encoding and decoding hydrogen-bond patterns of organic compounds Acc. Chem. Res. 1990, 23, 120-126
111. Macrae, C. F.; Bruno, I. J.; Chisholm, J. A.; Edgington, P. R.; McCabe, P.; Pidcock, E.; Rodriguez-Monge, L.; Taylor, R.; van de Streek, J.; Wood, P. A. Mercury CSD 2.0: new features for the visualization and investigation of crystal structures J. Appl. Crystallogr. 2008, 41, 466-470
112. Jorgensen, W. L.; Pranata, J. Importance of secondary interactions in triply hydrogen bonded complexes: guanine-cytosine vs uracil-2,6-diaminopyridine J. Am. Chem. Soc. 1990, 112, 2008-2010
113. Zimmerman, S. C.; Murray, T. J. New supramolecular architectures using hydrogen bonding Philos. Trans. R. Soc. London, Ser. A 1993, 345, 49-56
114. Scheiner, S.; Kar, T. Underlying source of the relation between polypeptide conformation and strength of NHO hydrogen bonds J. Mol. Struct. 2007, 844-845, 166-172
115. Luo, R.; David, L.; Hung, H.; Devaney, J.; Gilson, M. K. Strength of solvent-exposed salt-bridges J. Phys. Chem. B 1999, 103, 727-736
116. Hoertner, S. R.; Ritschel, T.; Stengl, B.; Kramer, C.; Schweizer, W. B.; Wagner, B.; Kansy, M.; Klebe, G.; Diederich, F. Potent inhibitors of tRNA-guanine transglycosylase, an enzyme linked to the pathogenicity of the Shigella bacterium: charge-assisted hydrogen bonding Angew. Chem., Int. Ed. 2007, 46, 8266-8269
117. Taylor, N. R.; Cleasby, A.; Singh, O.; Skarzynski, T.; Wonacott, A. J.; Smith, P. W.; Sollis, S. L.; Howes, P. D.; Cherry, P. C.; Bethell, R.; Colman, P.; Varghese, J. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4 H -pyran-6-carboxamides and sialidase from influenza virus types A and B J. Med. Chem. 1998, 41, 798-807
118. Klaholz, B. P.; Moras, D. C-HO hydrogen bonds in the nuclear receptor RAR gamma: a potential tool for drug selectivity Structure 2002, 10, 1197-1204
119. Tóth, G.; Bowers, S. G.; Truong, A. P.; Probst, G. The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceuctical relevance Curr. Pharm. Des. 2007, 13, 3476-3493
120. Desiraju, G. R.; Sarkel, S. N-HO, O-HO, and C-HO hydrogen bonds in protein-ligand complexes: strong and weak interactions in molecular recognition Proteins 2004, 54, 247-259
121. Tsuzuki, S.; Honda, K.; Uchimaru, T.; Mikami, M.; Tanaba, K. Origin of the attraction and directionality of the NH/p interaction: comparison with OH/pi and CH/pi interactions J. Am. Chem. Soc. 2000, 122, 11450-11458
122. Ottiger, P.; Pfaffen, C.; Leist, R.; Leutwyler, S.; Bachorz, R. A.; Klopper, W. Strong N-Hpi hydrogen bonding in amide-benzene interactions J. Phys. Chem. B 2009, 113, 2937-2943
123. Steiner, T.; Koellner, G. Hydrogen bonds with pi-acceptors in proteins: frequencies and role in stabilizing local 3D structures J. Mol. Biol. 2001, 305, 535-557
124. Imai, Y. N.; Inoue, Y.; Yamamoto, Y. Propensities of polar and aromatic amino acids in noncanonocal interactions: nonbonded contacts analysis of protein-ligand complexes in crystal structures J. Med. Chem. 2007, 50, 1189-1196
125. Foloppe, N.; Fisher, L. M.; Francis, G.; Howes, R.; Kierstan, P.; Potter, A. Identification of a buried pocket for potent and selective inhibition of Chk1: prediction and verification Bioorg. Med. Chem. Lett. 2002, 14, 1792-1804
126. Verhoest, P. R.; Chapin, D. S.; Corman, M.; Fonseca, K.; Harms, J. F.; Hou, X.; Marr, E. S.; Menniti, F. S.; Nelson, F.; O'Connor, R.; Pandit, J.; Proulx-LaFrance, C.; Schmidt, A. W.; Schmidt, C. J.; Suiciak, J. A.; Liras, S. Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920)(I) for the treatment of schizophrenia J. Med. Chem. 2009, 52, 5188-5196
127. Dunitz, J. D.; Taylor, R. Organic fluorine hardly ever accepts hydrogen bonds Chem. - Eur. J. 1997, 3, 89-98
128. Böhm, H.-J.; Banner, D.; Bendels, S.; Kansy, M.; Kuhn, B.; Müller, K.; Obst-Sander, U.; Stahl, M. Fluorine in medicinal chemistry ChemBioChem 2004, 5, 637-643
129. Parlow, J. J.; Kurumbail, R. G.; Stegeman, R. A.; Stevens, A. M.; Stallings, W. C.; South, M. S. Synthesis and X-ray crystal structures of substituted fluorobenzene and benzoquinone inhibitors of the tissue factor VIIa complex Bioorg. Med. Chem. Lett. 2003, 13, 3721-3725
130. Parlow, J. J.; Kurumbail, R. G.; Stegeman, R. A.; Stevens, A. M.; Stallings, W. C.; South, M. S. Design, synthesis, and crystal structure of selective 2-pyridone tissue factor VIIa inhibitors J. Med. Chem. 2003, 46, 4696-4701
131. Kim, D.; Wang, L.; Beconi, M.; Eiermann, G. J.; Fisher, M. H.; He, H.; Hickey, G. J.; Kowalchick, J. E.; Leiting, B.; Lyons, K.; Marsilio, F.; McCann, M. E.; Patel, R. A.; Petrov, A.; Scapin, G.; Patel, S. B.; Roy, R. S.; Wu, J. K.; Wyvratt, M. J.; Zhang, B. B.; Zhu, L.; Thornberry, N. A.; Weber, A. E. (2 R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- a ]pyrazin-7(8 H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes J. Med. Chem. 2005, 48, 141-151
132. Pierce, A. C.; Sandretto, K. L.; Bemis, G. W. Kinase inhibitors and the case for CHO hydrogen bonds in protein-ligand binding Proteins 2002, 49, 567-576
133. Pierce, A. C.; ter Haar, E.; Binch, H. M.; Kay, D. P.; Patel, S. R.; Li, P. CHO and CHN hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol- 2-ylamine protein kinase inhibitor J. Med. Chem. 2005, 48, 1278-1281
134. Vargas, R.; Garza, J.; Dixon, D. A.; Hay, B. P. How strong is the Calpha-H⋯O - C hydrogen bond? J. Am. Chem. Soc. 2000, 122, 4750-4755
135. Steiner, T. Water molecules which apparently accept no hydrogen bonds are systematically involved in C-HC interactions Acta Crystallogr. 1995, D51, 93-97
136. Olsen, J. A.; Banner, D. W.; Seiler, P.; Sander, U. O.; D'Arcy, A.; Stihle, M.; Mueller, K.; Diederich, F. A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: evidence for C-FC - O interactions Angew. Chem., Int. Ed. 2003, 42, 2507-2511
137. Chakrabarti, P.; Bhattacharyya, R. Geometry of nonbonded interactions involving planar groups in proteins Prog. Biophys. Mol. Biol. 2007, 95, 83-137 (Pubitemid 47513187)
138. Ramasubbu, N.; Parthasarathy, R.; Murray-Rust, P. Angular preferences of intermolecular forces around halogen centers: preferred directions of approach of electrophiles and nucleophiles around the carbon-halogen bond J. Am. Chem. Soc. 1986, 108, 4308-4314
139. Clark, T.; Hennemann, M.; Murray, J. S.; Politzer, P. Halogen bonding: the sigma hole J. Mol. Model. 2007, 13, 291-296
140. Lommerse, J. P. M.; Stone, A. J.; Taylor, R.; Allen, F. H. The nature and geometry of intermolecular interactions between halogens and oxygen or nitrogen J. Am. Chem. Soc. 1996, 118, 3108-3116
141. 13C NMR study of halogen bonding of haloarenes: measurement of solvent effects and theoretical analyses J. Am. Chem. Soc. 2004, 126, 4412-4419
142. Sarwar, M. G.; Dragisic, B.; Salsberg, L. J.; Gouliaras, C.; Taylor, M. S. Thermodynamics of halogen bonding in solution: substituent, structural, and solvent effects J. Am. Chem. Soc. 2010, 132, 1646-1653
143. Riley, K. E.; Merz, K. M., Jr. Insights into the strength and origin of halogen bonding: the halobenzene-formaldehyde dimer J. Phys. Chem. A 2007, 111, 1688-1694
144. Aakeroey, C. B.; Fasulo, M.; Schultheiss, N.; Desper, J.; Moore, C. Structural competition between hydrogen bonds and halogen bonds J. Am. Chem. Soc. 2007, 129, 13772-13773
145. Lu, Y.; Shi, T.; Wang, Y.; Yang, H.; Yan, X.; Luo, X.; Jiang, H.; Zhu, W. Halogen bonding - a novel interaction for rational drug design? J. Med. Chem. 2009, 52, 2854-2862
146. Auffinger, P.; Hays, F. A.; Westhof, E.; Ho, P. S. Halogen bonds in biological molecules Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 16789-16794
147. Metrangolo, P.; Neukirch, H.; Pilati, T.; Resnati, G. Halogen bonding based recognition processes: a world parallel to hydrogen bonding Acc. Chem. Res. 2005, 38, 386-395
148. Iltzsch, M. H.; Uber, S. S.; Tankersley, K. O.; el Kouni, M. H. Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii Biochem. Pharmacol. 1995, 49, 1501-1512
149. Parks, D. J.; LaFrance, L. V.; Calvo, R. R.; Milkiewicz, K. L.; Gupta, V.; Lattanze, J.; Ramachandren, K.; Carver, T. E.; Petrella, E. C.; Cummings, M. D.; Maguire, D.; Grasberger, B. L.; Lu, T. 1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR Bioorg. Med. Chem. Lett. 2005, 15, 765-770
150. Benjahad, A.; Guillemont, J.; Andries, K.; Nguyen, C. H.; Grierson, D. S. 3-Iodo-4-phenoxypyridinones (IOPY's), a new family of highly potent non-nucleoside inhibitors of HIV-1 reverse transcriptase Bioorg. Med. Chem. Lett. 2003, 13, 4309-4312
151. Himmel, D. M.; Das, K.; Clark, A. D., Jr.; Hughes, S. H.; Benjahad, A.; Oumouch, S.; Guillemont, J.; Coupa, S.; Poncelet, A.; Csoka, I.; Meyer, C.; Andries, K.; Nguyen, C. H.; Grierson, D. S.; Arnold, E. Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains J. Med. Chem. 2005, 48, 7582-7591
152. Regier Voth, A.; Khuu, P.; Oishi, K.; Ho, P. S. Halogen bonds as orthogonal molecular interactions to hydrogen bonds Nat. Chem. 2009, 1, 74-79
153. Maillard, M. C.; Hom, R. K.; Benson, T. E.; Moon, J. B.; Mamo, S.; Bienkowski, M.; Tomasselli, A. G.; Woods, D. D.; Prince, D. B.; Paddock, D. J.; Emmons, T. L.; Tucker, J. A.; Dappen, M. S.; Brogley, L.; Thorsett, E. D.; Jewett, N.; Sinha, S.; John, V. Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human β-secretase J. Med. Chem. 2007, 50, 776-781
154. Heath, R. J.; Yu, Y.-T.; Shapiro, M. A.; Olson, E.; Rock, C. O. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis J. Biol. Chem. 1998, 273, 30316-30320
155. Freundlich, J. S.; Anderson, J. W.; Sarantakis, D.; Shieh, H.-M.; Yu, M.; Valderramos, J.-C.; Lucumi, E.; Kuo, M.; Jacobs, W. R.; Fidock, D. A.; Schiehser, G. A.; Jacobus, D. P.; Sacchettini, J. C. Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4′-Substituted triclosan derivatives Bioorg. Med. Chem. Lett. 2005, 15, 5247-5252
156. Paulini, R.; Müller, K.; Diederich, F. Orthogonal multipolar interactions in structural chemistry and biology Angew. Chem., Int. Ed. 2005, 44, 1788-1805
157. Manas, E. S.; Unwalla, R. J.; Xu, Z. B.; Malamas, M. S.; Miller, C. P.; Harris, H. A.; Hsiao, C.; Akopian, T.; Hum, W.-T.; Malakian, K.; Wolfrom, S.; Bapat, A.; Bhat, R. A.; Stahl, M. L.; Somers, W. S.; Alvarez, J. C. Structure-based design of estrogen receptor-β selective ligands J. Am. Chem. Soc. 2004, 126, 15106-15119
158. Zhou, P.; Zou, J.; Tian, F.; Shang, Z. Fluorine bonding. How does it work in protein-ligand interactions? J. Chem. Inf. Model. 2009, 49, 2344-2355
159. Müller, K.; Faeh, C.; Diederich, F. Fluorine in pharmaceuticals: looking beyond intuition Science 2007, 317, 1881-1886
160. Dimicoli, J. L.; Bieth, J.; Lhoste, J. M. Trifluoroacetylated peptides as substrates and inhibitors of elastase: a nuclear magnetic resonance study Biochemistry 1976, 15, 2230-2236
161. Hughes, D. L.; Sieker, L. C.; Bieth, J.; Dimicoli, J. L. Crystallographic study of the binding of a trifluoroacetyl dipeptide anilide inhibitor with elastase J. Mol. Biol. 1982, 162, 645-658
162. Cowan-Jacob, S. W.; G., F.; Floersheimer, A.; Furet, P.; Liebetanz, J.; Rummel, G.; Rheinberger, P.; Centeleghe, M.; D., F.; Manley, P. W. Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia Acta Crystallogr. 2007, D63, 80-93
163. Crowan-Jacob, S. Personal communication in 2009.
164. Cox, C. D.; Breslin, M. J.; Mariano, B. J.; Coleman, P. J.; Buser, C. A.;
165. Swierczynski, D.; Luboradzki, R.; Dolgonos, G.; Lipkowski, J.; Schneider, H.-J. Non-covalent interactions of organic halogen compounds with aromatic systems: analyses of crystal structure data Eur. J. Org. Chem. 2005, 1172-1177
166. Prasanna, M. D.; Row, T. N. G. C-halogen-pi interactions and their influence on molecular conformation and crystal packing: a database study Cryst. Eng. 2000, 3, 135-154
167. Carosati, E.; Sciabola, S.; Cruciani, G. Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field J. Med. Chem. 2004, 47, 5114-5125
168. Matter, H.; Nazare, M.; Guessregen, S.; Will, D. W.; Schreuder, H.; Bauer, A.; Urmann, M.; Ritter, K.; Wagner, M.; Wehner, V. Evidence for C-Cl/C-Br-pi interactions as an important contribution to protein-ligand binding affinity Angew. Chem., Int. Ed. 2009, 48, 2911-2916
169. Di Magno, S. G.; Sun, H. The strength of weak interactions: aromatic fluorine in drug design Curr. Top. Med. Chem. 2006, 6, 1473-1482
170. Desiraju, G. R. Hydrogen bridges in crystal engineering: interactions without borders Acc. Chem. Res. 2002, 35, 565-573
171. Imai, Y. N.; Inoue, Y.; Nakanishi, I.; Kitaura, K. Cl-p interactions in protein-ligand complexes Protein Sci. 2008, 17, 1129-1137
172. Roehrig, S.; Straub, A.; Pohlmann, J.; Lampe, T.; Pernerstorfer, J.; Schlemmer, K.-H.; Reinemer, P.; Perzborn, E. Discovery of the novel antithrombotic agent 5-chloro- N -({(5 S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor J. Med. Chem. 2005, 48, 5900-5908
173. Baum, B.; Mohamed, M.; Zayed, M.; Gerlach, C.; Heine, A.; Hangauer, D.; Klebe, G. More than a simple lipophilic contact: a detailed thermodynamic analysis of nonbasic residues in the S1 pocket of thrombin J. Mol. Biol. 2009, 390, 56-69
174. Adams, H.; Cockroft, S. L.; Guardigli, C.; Hunter, C. A.; Lawson, K. R.; Perkins, J.; Spey, S. E.; Urch, C. J.; Ford, R. Experimental measurement of noncovalent interactions between halogens and aromatic rings ChemBioChem 2004, 5, 657-665
175. Dunitz, J. D. Organic fluorine: odd man out ChemBioChem 2004, 5, 614-621
176. Morgenthaler, M.; Aebi, J. D.; Grüninger, F.; Mona, D.; Wagner, B.; Kansy, M.; Diederich, F. A fluorine scan of non-peptidic inhibitors of neprilysin: fluorophobic and fluorophilic regions in an enzyme active site J. Fluorine Chem. 2008, 129, 852-856
177. Boehm, H.-J.; Klebe, G. What can we learn from molecular recognition in protein-ligand complexes for the design of new drugs? Angew. Chem., Int. Ed. 1996, 35, 2588-2614
178. Vallone, B.; Miele, A. E.; Vecchini, P.; Chiancone, E.; Brunori, M. Free energy of burying hydrophobic residues in the interface between protein subunits Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 6103-6107
179. Southall, N. T.; Dill, K. A.; Haymet, A. D. J. A view of the hydrophobic effect J. Phys. Chem. B 2002, 106, 521-533
180. Mecozzi, S.; Rebek, J. The 55% solution: a formula for molecular recognition in the liquid state Chem. - Eur. J. 1998, 4, 1016-1022
181. Zurcher, M.; Diederich, F. Structure-based drug design: exploring the proper filling of apolar pockets at enzyme active sites J. Org. Chem. 2008, 73, 4345-4361
182. Kuhn, B.; Hennig, M.; Mattei, P. Molecular recognition of ligands in dipeptidyl peptidase IV Curr. Top. Med. Chem. 2007, 7, 609-619
183. Peters, J.-U.; Weber, S.; Kritter, S.; Weiss, P.; Wallier, A.; Boehringer, M.; Hennig, M.; Kuhn, B.; Loeffler, B.-M. Aminomethylpyrimidines as novel DPP-IV inhibitors: a 100?000-fold activity increase by optimization of aromatic substituents Bioorg. Med. Chem. Lett. 2004, 14, 1491-1493
184. Boehringer, M.; Fischer, H.; Hennig, M.; Hunziker, D.; Huwyler, J.; Kuhn, B.; Loeffler, B. M.; Luebbers, T.; Mattei, P.; Narquizian, R.; Sebokova, E.; Sprecher, U.; Wessel, H. P. Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors Bioorg. Med. Chem. Lett. 2010, 20, 1106-1108
185. Carey, C.; Cheng, Y. K.; Rossky, P. J. Hydration structure of the α-chymotrypsin substrate binding pocket: the impact of constrained geometry Chem. Phys. 2000, 258, 415-425
186. Brandl, M.; Weiss, M. S.; Jabs, A.; Suehnel, J.; Hilgenfeld, R. CH-pi-interactions in proteins J. Mol. Biol. 2001, 307, 357-377
187. Burley, S. K.; Petsko, G. A. Aromatic-aromatic interaction: a mechanism of protein structure-stabilization Science 1985, 229, 23-28
188. Burley, S. K.; Petsko, G. A. Weakly polar interactions in proteins Adv. Protein Chem. 1988, 39, 125-89
189. Tsuzuki, S.; Honda, K.; Uchimaru, T.; Mikami, M.; Tanabe, K. Origin of attraction and directionality of the pi/pi interaction: model chemistry calculations of benzene dimer interaction J. Am. Chem. Soc. 2002, 124, 104-112
190. Grover, J. R.; Walters, E. A.; Hui, E. T. Dissociation energies of the benzene dimer and dimer cation J. Phys. Chem. 1987, 91, 3233-3237
191. Krause, H.; Ernstberger, B.; Neusser, H. J. Binding energies of small benzene clusters Chem. Phys. Lett. 1991, 184, 411-417
192. McGaughey, G. B.; Gagné, M.; Rappé, A. K. Pi-stacking interactions - alive and well in proteins J. Biol. Chem. 1998, 273, 15458-15463
193. Mecozzi, S.; West, A. P., Jr.; Dougherty, D. A. Cation-pi interactions in aromatics of biological and medicinal interest: electrostatic potential surfaces as a useful qualitative guide Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 10566-10571
194. Wheeler, S. E.; Houk, K. N. Through-space effects of substituents dominate molecular electrostatic potentials of substituted arenes J. Chem. Theory Comput. 2009, 5, 2301-2312
195. Sinnokrot, M. O.; Sherrill, C. D. Substituent effects in pi-pi interactions: sandwich and T-shaped configurations J. Am. Chem. Soc. 2004, 126, 7690-7697
196. Turk, J. A.; Smithrud, D. B. Synthesis and physical properties of protein core mimetics J. Org. Chem. 2001, 66, 8328-8335
197. Tsuzuki, S.; Honda, K.; Uchimaru, T.; Mikami, M.; Tanabe, K. The magnitude of the CH/pi interaction between benzene and some model hydrocarbons J. Am. Chem. Soc. 2000, 122, 3746-3753
198. Tsuzuki, S.; Uchimaru, T. Magnitude and physical origin of intermolecular interactions of aromatic molecules: recent progress of computational studies Curr. Org. Chem. 2006, 10, 745-762
199. James, W. H., III; Muller, C. W.; Buchanan, E. G.; Nix, M. G. D.; Guo, L.; Roskop, L.; Gordon, M. S.; Slipchenko, L. V.; Gellman, S. H.; Zwier, T. S. Intramolecular amide stacking and its competition with hydrogen bonding in a small foldamer J. Am. Chem. Soc. 2009, 131, 14243-14245
200. Zbinden, K. G.; Anselm, L.; Banner, D. W.; Benz, J.; Blasco, F.; Decoret, G.; Himber, J.; Kuhn, B.; Panday, N.; Ricklin, F.; Risch, P.; Schlatter, D.; Stahl, M.; Thomi, S.; Unger, R.; Haap, W. Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit Eur. J. Med. Chem. 2009, 44, 2787-2795
201. Yuan, C.; St. Jean, D. J.; Liu, Q.; Cai, L.; Li, A.; Han, N.; Moniz, G.; Askew, B.; Hungate, R. W.; Johansson, L.; Tedenborg, L.; Pyring, D.; Williams, M.; Hale, C.; Chen, M.; Cupples, R.; Zhang, J.; Jordan, S.; Bartberger, M. D.; Sun, Y.; Emery, M.; Wang, M.; Fotsch, C. The discovery of 2-anilinothiazolones as 11b-HSD1 inhibitors Bioorg. Med. Chem. Lett. 2007, 17, 6056-6061
202. Hynes, J., Jr.; Dyckman, A. J.; Lin, S.; Wrobleski, S. T.; Wu, H.; Gillooly, K. M.; Kanner, S. B.; Lonial, H.; Loo, D.; McIntyre, K. W.; Pitt, S.; Shen, D. R.; Shuster, D. J.; Yang, X.; Zhang, R.; Behnia, K.; Zhang, H.; Marathe, P. H.; Doweyko, A. M.; Tokarski, J. S.; Sack, J. S.; Pokross, M.; Kiefer, S. E.; Newitt, J. A.; Barrish, J. C.; Dodd, J.; Schieven, G. L.; Leftheris, K. Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1- f ][1,2,4]triazine p38a mitogen-activated protein kinase inhibitors J. Med. Chem. 2008, 51, 4-16
203. Gallivan, J. P.; Dougherty, D. A. A computational study of cation-pi interactions vs salt bridges in aqueous media: implications for protein engineering J. Am. Chem. Soc. 2000, 122, 870-874
204. Gallivan, J. P.; Dougherty, D. A. Cation-pi nteractions in structural biology Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 9459-9464
205. Berry, B. W.; Elvekrog, M. M.; Tommos, C. Environmental modulation of protein cation-.pi. interactions J. Am. Chem. Soc. 2007, 129, 5308-5309
206. Oh, B.-H.; Ames, G. F.-L.; Kim, S.-H. Structural basis for multiple ligand specificity of the periplasmic lysine-, arginine-, ornithine-binding protein J. Biol. Chem. 1994, 269, 26323-26330
207. Soerme, P.; Arnoux, P.; Kahl-Knutsson, B.; Leffler, H.; Rini, J. M.; Nilsson, U. J. Structural and thermodynamic studies on cation-p interactions in lectin-ligand complexes: high-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction J. Am. Chem. Soc. 2005, 127, 1737-1743
208. Cumpstey, I.; Salomonsson, E.; Sundin, A.; Leffler, H.; Nilsson, U. J. Double affinity amplification of galectin-ligand interactions through arginine-arene interactions: synthetic, thermodynamic, and computational studies with aromatic diamido thiodigalactosides Chem. - Eur. J. 2008, 14, 4233-4245
209. Williamson, D. S.; Borgognoni, J.; Clay, A.; Daniels, Z.; Dokurno, P.; Drysdale, M. J.; Foloppe, N.; Francis, G. L.; Graham, C. J.; Howes, R.; Macias, A. T.; Murray, J. B.; Parsons, R.; Shaw, T.; Surgenor, A. E.; Terry, L.; Wang, Y.; Wood, M.; Massey, A. J. Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design J. Med. Chem. 2009, 52, 1510-1513
210. Biot, C.; Buisine, E.; Kwasigroch, J.-M.; Wintjens, R.; Rooman, M. Probing the energetic and structural role of amino acid/nucleobase cation-p interactions in protein-ligand complexes J. Biol. Chem. 2002, 277, 40816-40822
211. Celie, P. H. N.; van Rossum-Fikkert, S. E.; van Dijk, W. J.; Brejc, K.; Smit, A. B.; Sizma, T. K. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures Neuron 2004, 41, 907-914
212. Kryger, G.; Silman, I.; Sussman, J. L. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs Structure 1999, 7, 297-307
213. Salonen, L. M.; Bucher, C.; Banner, D. W.; Haap, W.; Mary, J.-L.; Benz, J.; Kuster, O.; Seiler, P.; Schweizer, W. B.; Diederich, F. Cation-pi interactions at the active site of factor Xa: dramatic enhancement upon stepwise N-alkylation of ammonium ions Angew. Chem., Int. Ed. 2009, 48, 811-814
214. Mo, Y.; Subramanian, G.; Gao, J.; Ferguson, D. M. Cation-pi interactions: an energy decomposition analysis and its implication in delta-opioid receptor-ligand binding J. Am. Chem. Soc. 2002, 124, 4832-4837
215. Hughes, R. M.; Benshoff, M. L.; Waters, M. L. Effects of chain length and N-methylation on a cation-.pi. interaction in a.beta.-hairpin peptide Chem. - Eur. J. 2007, 13, 5753-5764
216. Rosenfield, R. E.; Parthasarathy, R.; Dunitz, J. D. Directional preferences of nonbonded atomic contacts with divalent sulfur. 1. Electrophiles and nuclephiles J. Am. Chem. Soc. 1977, 99, 4860-4862
217. Grether, U.; Benardeau, A.; Benz, J.; Binggeli, A.; Blum, D.; Hilpert, H.; Kuhn, B.; Marki, H. P.; Meyer, M.; Mohr, P.; Puntener, K.; Raab, S.; Ruf, A.; Schlatter, D. Design and biological evaluation of novel, balanced dual PPAR alpha/gamma agonists ChemMedChem 2009, 4, 951-956
218. Duan, G. L.; Smith, V. H.; Weaver, D. F. Characterization of aromatic-thiol pi-type hydrogen bonding and phenylalanine-cysteine side chain interactions through ab initio calculations and protein database analyses J. Biomol. Struct. Dyn. 2001, 19, 115-128
219. Ringer, A. L.; Senenko, A.; Sherrill, C. D. Models of S/pi interactions in protein structures: Comparison of the H2S-benzene complex with PDB data Protein Sci. 2007, 16, 2216-2223
220. Pranata, J. Sulfur-aromatic interactions: a computational study of the dimethyl sulfide-benzene complex Bioorg. Chem. 1997, 25, 213-219
221. Pal, D.; Chakrabarti, P. Non-hydrogen bond interactions involving the methionine sulfur atom J. Biomol. Struct. Dyn. 2001, 19, 115-128
222. Zauhar, R. J.; Colbert, C. L.; Morgan, R. S.; Welsh, W. J. Evidence for a strong sulfur-aromatic interaction derived from crystallographic data Biopolymers 2000, 53, 233-248
223. Pilger, B. D.; Perozzo, R.; Alber, F.; Wurth, C.; Folkers, G.; Scapozza, L. Substrate diversity of herpes simplex virus thymidine kinase J. Biol. Chem. 1999, 274, 31967-31973
224. http://www.desertsci.com/ (accessed March 12, 2010).
225. Bruno, I. J.; Cole, J. C.; Edgington, P. R.; Kessler, M.; Macrae, C. F.; McCabe, P.; Pearson, J.; Taylor, R. New software for searching the Cambridge Structural Database and visualizing crystal structures Acta Crystallogr. 2002, B58, 389-397
226. Dalby, A.; Nourse, J. G.; Hounshell, W. D.; Gushurst, A. K. I.; Grier, D. L. Description of several chemical structure file formats used by computer programs developed at Molecular Design Ltd J. Chem. Inf. Comput. Sci. 1992, 32, 244-255
227. http://www.ccdc.cam.ac.uk/products/csd-system/prequest/ (accessed March 12, 2010).
228. DeLano, W. L. The PyMOL Molecular Graphics System; DeLano Scientific: Palo Alto, CA; http://www.pymol.org (accessed March 12, 2010).